Sanofi profits down despite growth at Genzyme unit

Sanofi profits down despite growth at Genzyme unit


Drugmaker Sanofi has reported an 11 percent fall in profit in the second quarter despite double-digit growth of its biotech unit Genzyme. The Paris-based company reported Friday a fall in net income of 11 percent to 1.16 billion euros and a 5 percent drop in net revenue to 8.14 billion euros.



from Biotech News